Antifungal Compounds against Candida Infections from Traditional Chinese Medicine
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Infections caused by Candida albicans, often refractory and with high morbidity and mortality, cause a heavy burden on the public health while the current antifungal drugs are limited and are associated with toxicity and resistance. Many plant-derived molecules including compounds isolated from traditional Chinese medicine (TCM) are reported to have antifungal activity through different targets such as cell membrane, cell wall, mitochondria, and virulence factors. Here, we review the recent progress in the anti-Candida compounds from TCM, as well as their antifungal mechanisms. Considering the diverse targets and structures, compounds from TCM might be a potential library for antifungal drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“The spatial, structural, and metabolic heterogeneity of biofilms is considered to promote influx of nutrients, efflux of waste products, and establishment of microniches, thus facilitating the adaption of biofilms to the hypoxic environment [99, 110].”
BackgroundKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · cited 2×
“Ergosterol plays important roles in regulating the fluidity of the cell membrane and cell division of fungal cells, while the structural and conformational differences between ergosterol and sterol (the counterpart of ergosterol in mammalian cells) underlie the antifungalmechanismof the polyenes such as amphotericin B…”
BackgroundThe glyoxylate cycle is required for fungal virulence
Lorenz, M. C., & Fink, G. R. (2001) · Nature · doi:10.1038/35083594 · Cited by 745
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524 · cited 1×
“When the hosts encounter lower functions of immune system (resulting from HIV infection, organ transplant, and cancer treatment [7]) or disequilibrium of microflora due to the use of antibiotics [8], mucocutaneous and superficial infections, such as oral thrush and vaginitis, come up.”
BackgroundFanning, S., & Mitchell, A. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002585 · Cited by 465 · cited 2×
“Biofilm, buried in the extracellular matrix (ECM), holds a complicated three-dimensional architecture consisting mainly of yeast form cells and hyphal cells with broad heterogeneity in space [15, 109].”
BackgroundAn insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375
Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect
Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., & Watanabe, N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3113-3117.2002 · Cited by 338
Biofilm Matrix Regulation by Candida albicans Zap1
Nobile, C. J., Nett, J. E., Hernday, A. D., Homann, O. R., Deneault, J.-S., Nantel, A., Andes, D. R., Johnson, A. D., & Mitchell, A. P. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000133 · Cited by 337
Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study
Lara, H. H., Romero-Urbina, D. G., Pierce, C., Lopez-Ribot, J. L., Arellano-Jiménez, M. J., & Jose-Yacaman, M. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0147-8 · Cited by 323 · cited 1×
“used for long as therapies for constipation, pains, jaundice, and rheumatism [155].”
Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms
Uppuluri, P., Nett, J., Heitman, J., & Andes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-07 · Cited by 228
Candida albicans Triggers NLRP3-Mediated Pyroptosis in Macrophages
Wellington, M., Koselny, K., Sutterwala, F. S., & Krysan, D. J. (2014) · Eukaryotic Cell · doi:10.1128/ec.00336-13 · Cited by 227
Antifungal therapy with an emphasis on biofilms
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & López-Ribot, J. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.008 · Cited by 173 · cited 6×
“Biofilm, buried in the extracellular matrix (ECM), holds a complicated three-dimensional architecture consisting mainly of yeast form cells and hyphal cells with broad heterogeneity in space [15, 109].”
BackgroundInfluentialInfection-related gene expression in Candida albicans
Brown, A. J. P., Odds, F. C., & Gow, N. A. R. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.04.001 · Cited by 148
Confronting the challenges of natural product-based antifungal discovery
Roemer, T., Xu, D., Singh, S. B., Parish, C. A., Harris, G., Wang, H., Davies, J. E., & Bills, G. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.01.009 · Cited by 147 · cited 2×
“Natural products provide a potential source for antifungal drugs, either in their nascent form or as original templates for structure-optimizing for more effective and safe derivatives [16, 17].”
Backgroundda Silva, A. R., de Andrade Neto, J. B., da Silva, C. R., Campos, R. D. S., Costa Silva, R. A., Freitas, D. D., do Nascimento, F. B. S. A., de Andrade, L. N. D., Sampaio, L. S., Grangeiro, T. B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01846-15 · Cited by 139
Xu, Y., Wang, Y., Yan, L., Liang, R.-M., Dai, B.-D., Tang, R.-J., Gao, P.-H., & Jiang, Y.-Y. (2009) · Journal of Proteome Research · doi:10.1021/pr9005074 · Cited by 113
The Hog1 MAP kinase controls respiratory metabolism in the fungal pathogen Candida albicans
Alonso-Monge, R., Carvaihlo, S., Nombela, C., Rial, E., & Pla, J. (2009) · Microbiology · doi:10.1099/mic.0.023309-0 · Cited by 105
SCY-078 is fungicidal against Candida species in time-kill studies
Scorneaux, B., Angulo, D., Borroto-Esoda, K., Ghannoum, M., Peel, M., & Wring, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01961-16 · Cited by 88
Ruy, F., Vercesi, A. E., & Kowaltowski, A. J. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9012-7 · Cited by 74
Sun, L.-M., Liao, K., Liang, S., Yu, P.-H., & Wang, D.-Y. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12737 · Cited by 67
Molecular Cloning and Functional Expression of Alternative Oxidase from Candida albicans
Huh, W.-K., & Kang, S.-O. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.4098-4102.1999 · Cited by 66
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata
DEFONTAINE, A., BOUCHARA, J.-P., DECLERK, P., PLANCHENAULT, C., CHABASSE, D., & HALLET, J.-N. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-7-663 · Cited by 65 · cited 1×
“glabrata to azoles is associated with mitochondrial DNA deficiency [45].”
BackgroundHa, T. K., Hansen, A. H., Kol, S., Kildegaard, H. F., & Lee, G. M. (2018) · Biotechnology Journal · doi:10.1002/biot.201700425 · Cited by 40 · cited 1×
“CHO cell), baicalin could reduce ROS production [69].”
Background
Cited by
Ahmed, L. I., Ibrahim, N., Abdel-Salam, A. B., & Fahim, K. M. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101177 · Cited by 83
Lone, S. A., Khan, S., & Ahmad, A. (2020) · Archives of Microbiology · doi:10.1007/s00203-019-01781-2 · Cited by 32
Wang, Y., He, Y., Cai, T., Lei, Z., Lei, W., Cao, Y., & Wu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27346 · Cited by 7
Metadata
- Authors
- Liu, X., Ma, Z., Zhang, J., & Yang, L.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-12
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2778441820
- Cited by
- 91
- References
- 29
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.